Moves to delay second dose of Pfizer vaccine not supported by test data
Wednesday, 13 January 2021 () (Natural News) BioNTech, the German biotech group that worked with Pfizer to develop the first Wuhan coronavirus (COVID-19) vaccine together to receive approval, warned that there was “no data” to support moves to delay the second dose of the vaccine. The delays had initially been proposed by the U.K. government as a means to get the first dose to...
FDA guidance indicates the vaccine's second dose should be administered three to four weeks after the initial dose, but Tri-State health officials and experts said there is no guarantee there will be..
Pfizer and BioNTech have agreed to supply their COVID-19 vaccine to the World Health Organization co-led COVAX vaccine access scheme, two sources familiar with the deal said, the latest in a series of..